NEWARK, DE — The global in-vitro human models market is entering a high-growth phase, projected to expand from USD 2,123.8 million in 2026 to USD 8,443.7 million by 2036, registering a CAGR of 14.8%, according to Future Market Insights (FMI). Growth is being fueled by increasing demand for human-relevant testing platforms that improve predictive accuracy, reduce late-stage drug...